Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2824]

Novel triplet regimen yields promising response in advanced-phase chronic myeloid leukaemia

Novel triplet regimen yields promising response in advanced-phase chronic myeloid leukaemia

FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma

FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma

ESMO 2024: Survival benefits from adding perioperative durvalumab to chemo in MIBC

ESMO 2024: Survival benefits from adding perioperative durvalumab to chemo in MIBC

ESMO 2024: Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human...

ESMO 2024: Trastuzumab deruxtecan effective against brain mets in HER2-positive breast cancer

ESMO 2024: Trastuzumab deruxtecan effective against brain mets in HER2-positive breast cancer

Researcher develops drug delivery system for chemo-induced hearing loss

Researcher develops drug delivery system for chemo-induced hearing loss

University develops novel bone cancer therapy which has 99% success rate

University develops novel bone cancer therapy which has 99% success rate

ESMO 2024: Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

ESMO 2024: Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone...

WCLC 2024: Amivantamab-vmjw plus lazertinib show strong favourable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer

WCLC 2024: Amivantamab-vmjw plus lazertinib show strong favourable overall survival trend versus osimertinib in...

Research Spotlight: association of statin, metformin, and aspirin use with hepatocellular carcinoma in the all of us research program

Research Spotlight: association of statin, metformin, and aspirin use with hepatocellular carcinoma in the all of...

More from ecancer